Xvivo Perfusion AB

STO:XVIVO

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XVIVO's stock price target?

Price Target

390.92 SEK

According to Wall Street analysts, the average 1-year price target for XVIVO is 390.92 SEK with a low forecast of 343.4 SEK and a high forecast of 446.25 SEK.

What is Xvivo Perfusion AB's Revenue forecast?

Projected CAGR

33%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's revenue is 22%. The projected CAGR for the next 3 years is 33%.

What is Xvivo Perfusion AB's Operating Income forecast?

Projected CAGR

308%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's operating income is -4%. The projected CAGR for the next 3 years is 308%.

What is Xvivo Perfusion AB's Net Income forecast?

Projected CAGR

48%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's net income is 43%. The projected CAGR for the next 3 years is 48%.